Zhou Q, Xiao M, Nicoll R A
Departments of Cellular and Molecular Pharmacology and Physiology, University of California, San Francisco, CA 94143, USA.
Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1261-6. doi: 10.1073/pnas.98.3.1261. Epub 2001 Jan 23.
Trafficking of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPARs) at synapses has been suggested to play an important role in the expression of synaptic plasticity. Both the regulated and the constitutive trafficking of synaptic AMPARs are thought to involve the insertion and removal of receptors by means of an exocytotic and endocytotic process, respectively. In contrast, N-methyl-d-aspartate (NMDA) receptors (NMDARs), which are colocalized with AMPARs at excitatory synapses, appear to be much less dynamic. Here, we present evidence supporting the idea that synaptic AMPARs turn over through a constitutive endocytotic process and that glutamate application greatly enhances this turnover of AMPARs. The glutamate-induced internalization of AMPARs requires a rise in postsynaptic Ca(2+). The AMPAR internalization is mimicked by latrunculin A, a drug that selectively depolymerizes actin and is blocked by jasplakinolide, a drug which stabilizes actin filaments. The rate of endocytosis is not altered by glutamate application, whereas a clear enhancement is observed with insulin application. We propose a model in which the glutamate-induced dissociation of AMPARs from their anchor on the postsynaptic membrane involves actin depolymerization, which allows the released AMPARs to segregate from the NMDARs and diffuse to a presumably perisynaptic site, where they become available to an endocytotic machinery and are selectively internalized.
突触处α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体(AMPARs)的转运被认为在突触可塑性的表达中起重要作用。突触AMPARs的调节性转运和组成性转运分别被认为涉及通过胞吐和胞吞过程插入和移除受体。相比之下,在兴奋性突触处与AMPARs共定位的N-甲基-D-天冬氨酸(NMDA)受体(NMDARs)似乎动态性要低得多。在此,我们提供证据支持以下观点:突触AMPARs通过组成性胞吞过程进行周转,并且谷氨酸的应用极大地增强了AMPARs的这种周转。谷氨酸诱导的AMPARs内化需要突触后Ca²⁺浓度升高。AMPARs的内化可被Latrunculin A模拟,Latrunculin A是一种能选择性使肌动蛋白解聚的药物,而其可被能稳定肌动蛋白丝的药物jasplakinolide阻断。谷氨酸的应用不会改变内吞速率,而胰岛素的应用则会明显增强内吞速率。我们提出了一个模型,其中谷氨酸诱导AMPARs从突触后膜上的锚定物解离涉及肌动蛋白解聚,这使得释放的AMPARs与NMDARs分离并扩散到一个可能位于突触周围的位点,在那里它们可被内吞机制利用并被选择性内化。